HEATHER STANG: Open Payments
NPI 1710455605 · BERLIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,559 in 83 payments from 22 companies in 2025. Trend: 2023 $3,335 · 2024 $2,233 · 2025 $1,559
Food & beverage: $1,559
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $354 |
| Amgen Inc. | 16 | $274 |
| Lilly USA, LLC | 13 | $196 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $103 |
| Alkermes, Inc. | 6 | $101 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $50 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| Ardelyx, Inc. | 2 | $40 |
Products named: QULIPTA, EVENITY, REXULTI, OMVOH, XIFAXAN, VIVITROL, MOUNJARO, UBRELVY.
Industry payments across NJ — which companies pay providers there.
